End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,682 MXN | +0.06% |
|
-0.79% | +1.36% |
Jun. 28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
Jun. 28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Turnover
EBIT
Dividend / Share (DPS)
- Stock Market
- Equities
- JNJ Stock
- JNJ * Stock
- Revisions Johnson & Johnson